SpectraCure AB (publ) (SPEC.ST)
SpectraCure AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $0.02, up 0.00% on the session, giving a market capitalisation of $10.5M. Its beta of 0.30 implies it has historically moved less than the broad market.
SpectraCure AB (publ) specializes in oncology, developing innovative cancer treatments that harness laser light and photodynamic agents. A cornerstone of their research is the IDOSE software, which powers an interstitial photodynamic therapy (PDT) system. This cutting-edge system is currently in Phase II clinical trials, where its efficacy in addressing solid tumors is being evaluated. The Swedish company, established in Lund in 2003, continues to advance its therapeutic solutions.
SpectraCure AB (publ) is most often compared with the following Healthcare names: